Sulfalene
Based on 1 Customer Validation
Sulfalene (Sulfametopyrazine) is an orally active antimalarial agent. Sulfalene competes with para-aminobenzoic acid in plasmodial and bacterial folic acid synthesis pathways. Sulfalene reduces trachoma-associated pathological changes. Sulfalene can be used for the research of acute falciparum malaria, Schistosoma mansoni infection, trachoma, chronic bronchitis, and bacteriuria in pregnancy.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.73%
- CAS 番号: 152-47-6
- 分子式: C11H12N4O3S
- 分子量:280.30
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
-
溶剤 & 溶解度
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
-
Antibacterial Compound Library
HY-L049
-
Anti-COVID-19 Compound Library
HY-L052
-
NMPA-Approved Drug Library
HY-L053
-
Orally Active Compound Library
HY-L061
-
FDA Approved & Pharmacopeial Drug Library
HY-L066
-
Antiparasitic Compound library
HY-L082
-
Human Metabolite Library
HY-L123
-
Withdrawn Drug Compound Library
HY-L140
-
Off-patent Drug Library
HY-L141
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Drug Repurposing Compound Library Plus
HY-L035P
-
FDA-Approved Drug Library Plus
HY-L022P
-
FDA-Approved Drug Library Mini
HY-L022M
-
Bioactive Compound Library
HY-L001
-
High-Throughput Bioactive Compound Library
HY-L205
-
Mass Spectrometry Human Metabolite Library
HY-L215
-
Anti-Infection Compound Library
HY-L002
-
Immunology/Inflammation Compound Library
HY-L007
-
FDA-Approved Drug Library
HY-L022
-
Peptidomimetic Library
HY-L033
-
Drug Repurposing Compound Library
HY-L035
Parasite アイソフォーム固有の製品をすべて表示
More
生物活性
|
Plasmodium |
Sulfalene exhibits antitrachoma activity in yolk sacs of embryonated chicken eggs[3].
Sulfalene has a free, active fraction of 35%-45% in human plasma, representing a higher biologically available portion than Fanasil[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 152-47-6
-
性状 Solid
-
分子量 280.30
-
分子式 C11H12N4O3S
-
Color White to off-white
-
SMILES
O=S(C1=CC=C(N)C=C1)(NC2=NC=CN=C2OC)=O
-
別名
Sulfametopyrazine; AS-18908
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
溶剤 & 溶解度
DMSO : 100 mg/mL (356.76 mM; Need ultrasonic and warming; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (288 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Martin DC, et al. Treatment of acute falciparum malaria with sulfalene and trimethoprim. JAMA. 1968 Feb 12;203(7):476-80. [Content Brief]
[2]. Obonyo CO, et al. Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial. Lancet Infect Dis. 2010;10(9):603-611. [Content Brief]
[3]. Bietti GB, et al. Further contributions to the intermittent therapy of trachoma with new long-acting sulfonamides. Am J Ophthalmol. 1967 May;63(5):Suppl:1569-73. [Content Brief]
[4]. Darke CS, et al. Sulfametopyrazine in the prophylaxis of exacerbations of chronic bronchitis. Br J Dis Chest. 1972 Oct;66(4):276-83. [Content Brief]
[5]. Reeves DS. Laboratory and clinical studies with sulfametopyrazine as a treatment for bacteriuria in pregnancy. J Antimicrob Chemother. 1975 Jun;1(2):171-86. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.5676 mL | 17.8380 mL | 35.6761 mL | 89.1902 mL |
| 5 mM | 0.7135 mL | 3.5676 mL | 7.1352 mL | 17.8380 mL | |
| 10 mM | 0.3568 mL | 1.7838 mL | 3.5676 mL | 8.9190 mL | |
| 15 mM | 0.2378 mL | 1.1892 mL | 2.3784 mL | 5.9460 mL | |
| 20 mM | 0.1784 mL | 0.8919 mL | 1.7838 mL | 4.4595 mL | |
| 25 mM | 0.1427 mL | 0.7135 mL | 1.4270 mL | 3.5676 mL | |
| 30 mM | 0.1189 mL | 0.5946 mL | 1.1892 mL | 2.9730 mL | |
| 40 mM | 0.0892 mL | 0.4460 mL | 0.8919 mL | 2.2298 mL | |
| 50 mM | 0.0714 mL | 0.3568 mL | 0.7135 mL | 1.7838 mL | |
| 60 mM | 0.0595 mL | 0.2973 mL | 0.5946 mL | 1.4865 mL | |
| 80 mM | 0.0446 mL | 0.2230 mL | 0.4460 mL | 1.1149 mL | |
| 100 mM | 0.0357 mL | 0.1784 mL | 0.3568 mL | 0.8919 mL |
Sulfalene 関連分類
HY-A0130 関連分類
Powered by Bioz